Julie Maja Leth

Julie Maja Leth is a researcher at the Biotech Research & Innovation Centre (BRIC) within the University of Copenhagen, working in the Ploug Group. Her research focuses on the urokinase-type plasminogen activator receptor (uPAR) and its applications in cancer diagnostics and therapeutics. She maintains an active research profile with publications spanning molecular imaging, peptide engineering, and biochemical analysis of protein interactions.

Her research interests center on developing molecular imaging techniques for cancer detection, particularly through uPAR-targeted approaches. This includes creating peptide-based imaging agents for fluorescence-guided surgery, optimizing radiolabeling techniques for PET imaging, and investigating the structural biology of uPAR interactions. Her work bridges biochemistry, oncology, and medical imaging to develop novel diagnostic and therapeutic strategies.

Analysis of her publication record shows consistent contributions to molecular imaging techniques, with particular emphasis on uPAR-targeted applications across multiple cancer types. Her research demonstrates progression from fundamental biochemical studies of protein interactions toward translational applications in surgical oncology and diagnostic imaging.

Dr. Leth actively collaborates with the Ploug and Kjaer research groups at BRIC, contributing to both basic science investigations of protein receptor biology and applied research in cancer diagnostics. Her work has been referenced in multiple patents, indicating translational potential of her research.

Her laboratory work centers on the Ploug Group at BRIC, where she investigates uPAR receptor biology using biochemical, biophysical, and imaging approaches. The research environment supports both fundamental studies of protein interactions and applied development of imaging agents for clinical translation.